Elicio Therapeutics Secures Funding Through Private Placement of 1.03M Shares at $5.81
Monday, 18 March 2024, 13:51
Elicio Therapeutics Announces Private Placement Financing
Elicio Therapeutics has revealed plans to sell 1.03 million shares at $5.81 each in a private placement financing deal. The move is aimed at securing additional capital to fuel the company's growth and development efforts in the highly competitive biotech sector.
Key Details:
- Share Offering: 1.03M shares
- Price: $5.81 per share
The announcement has garnered significant attention from investors and industry experts, highlighting the confidence in Elicio Therapeutics' innovative approach to cancer treatment.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.